Literature DB >> 26232071

Protection effect of piperine and piperlonguminine from Piper longum L. alkaloids against rotenone-induced neuronal injury.

Hao Wang1, Jia Liu1, Ge Gao1, Xia Wu1, Xiaomin Wang1, Hui Yang2.   

Abstract

Currently available treatment approaches for Parkinson׳s disease (PD) are limited in terms of variety and efficacy. Piper longum L. (PLL; Piperaceae) is used in traditional medicine in Asia and the Pacific Islands, with demonstrated anti-inflammatory and antioxidant activities in preclinical studies, and alkaloid extracts of PLL have shown protective effects in PD models. The present study investigated the mechanistic basis for the observed protective effects of PLL. Rats treated with PLL-derived alkaloids showed improvement in rotenone-induced motor deficits, while reactive oxygen species (ROS) production was decreased, mitochondrial membrane potential was stabilized, and the opening of the mitochondrial permeability transition pore (mPTP)-which is involved in ROS production-was inhibited. In addition, rotenone-induced apoptosis was abrogated in the presence of these alkaloids, while a pretreatment stimulated autophagy, likely mitigating neuronal injury by the removal of damaged mitochondria. These findings provide novel insight into the neuroprotective function of PLL as well as evidence in favor of its use in PD treatment. This article is part of a Special Issue entitled SI: Neuroprotection.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  Mitochondrial permeability transition pore; Parkinson׳s disease; Treatment

Mesh:

Substances:

Year:  2015        PMID: 26232071     DOI: 10.1016/j.brainres.2015.07.029

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  9 in total

1.  A selective and sensitive UFLC-MS/MS method for the simultaneous determination of five alkaloids from Piper longum L. and its application in the pharmacokinetic study of 6-OHDA-induced Parkinson's disease rats.

Authors:  Rongrong Xu; Wenwen Zhao; Lan Yu; Qijun Chen; Xiaolu Hu; Yinying Ba; Xiaoqing Chen; Xing Wang; Xia Wu
Journal:  RSC Adv       Date:  2019-11-12       Impact factor: 4.036

2.  Improved neuroprotective effect of resveratrol nanoparticles as evinced by abrogation of rotenone-induced behavioral deficits and oxidative and mitochondrial dysfunctions in rat model of Parkinson's disease.

Authors:  Suresh Palle; Prasad Neerati
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-02-06       Impact factor: 3.000

3.  Alkaloids from piper longum protect dopaminergic neurons against inflammation-mediated damage induced by intranigral injection of lipopolysaccharide.

Authors:  Huan He; Wei-Wei Guo; Rong-Rong Xu; Xiao-Qing Chen; Nan Zhang; Xia Wu; Xiao-Min Wang
Journal:  BMC Complement Altern Med       Date:  2016-10-24       Impact factor: 3.659

4.  Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models.

Authors:  Jia Liu; Weijin Liu; Yongquan Lu; Hao Tian; Chunli Duan; Lingling Lu; Ge Gao; Xia Wu; Xiaomin Wang; Hui Yang
Journal:  Autophagy       Date:  2018-02-21       Impact factor: 16.016

Review 5.  Resveratrol Brain Delivery for Neurological Disorders Prevention and Treatment.

Authors:  Stephanie Andrade; Maria João Ramalho; Maria do Carmo Pereira; Joana A Loureiro
Journal:  Front Pharmacol       Date:  2018-11-20       Impact factor: 5.810

6.  Neuroprotective effects of pomegranate (Punica granatum L.) juice and seed extract in paraquat-induced mouse model of Parkinson's disease.

Authors:  Samah M Fathy; Heba A El-Dash; Noha I Said
Journal:  BMC Complement Med Ther       Date:  2021-04-26

7.  Synergistic effect of ursolic acid and piperine in CCl4 induced hepatotoxicity.

Authors:  Sayan Biswas; Amit Kar; Nanaocha Sharma; Pallab K Haldar; Pulok K Mukherjee
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

8.  Piperine induces autophagy by enhancing protein phosphotase 2A activity in a rotenone-induced Parkinson's disease model.

Authors:  Jia Liu; Min Chen; Xue Wang; Yi Wang; Chunli Duan; Ge Gao; Lingling Lu; Xia Wu; Xiaomin Wang; Hui Yang
Journal:  Oncotarget       Date:  2016-09-20

Review 9.  Piperine and Its Metabolite's Pharmacology in Neurodegenerative and Neurological Diseases.

Authors:  Shofiul Azam; Ju-Young Park; In-Su Kim; Dong-Kug Choi
Journal:  Biomedicines       Date:  2022-01-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.